Immunex Message Board - Msg: 16799501

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Curtis who wrote (629)	12/17/2001 8:29:37 AM
From: LemurHouse	Read Replies (2) of 656

I hate the deal. $30, assuming Amgen doesn't continue to fall. IMNX is giving much more than they are getting, and I can only think that AHP is driving this thing by pushing their 41%. I think IMNX could easily have run to $40-$50 by the spring/summer, on market overreaction to Enbrel supply improvements and exploding sales. But with this deal I'll be out of the stock long before then. Maybe today. Conf call at 9:00 EST this morning. It was a great run while it lasted. Does anyone have any suggestions re smaller biotechs with promising late-stage drugs at or near approval? AD

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next